You are here: Industry Insights > SARS-CoV-2

News List

COVID-19 vaccine induces immune response in Phase I trial europeanpharmaceuticalreview
May 27, 2020
The adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine candidate safely induced T cell and antibody responses in 108 adults.
‘At home’ COVID-19 antibody tests: expert opinions and manufacturer warnings europeanpharmaceuticalreview
May 27, 2020
Abbott has revealed it’s SARS-CoV-2 antibody test was not designed for at home use despite companies selling them for this purpose. Also, what do experts think about these tests?
Moderna’s Phase I Interim Data of mRNA-1273 Shows Promise contractpharma
May 27, 2020
Dose dependent increases in immunogenicity against SARS-CoV-2 were seen across the three dose levels.
Merck to Acquire Themis contractpharma
May 27, 2020
Will apply its vaccine development capabilities to SARS-CoV-2 vaccine program originated by Themis and Institut Pasteur.
First COVID-19 vaccine human trial finds it is safe, induces immune response expresspharma
May 27, 2020
According to the study of 108 adults, the vaccine produced neutralising antibodies, and a response mediated by the immune system's T-cells against the novel coronavirus, SARS-CoV-2.
Moderna’s Covid-19 vaccine shows significant effect in early human trial pharmaceutical-business-review
May 21, 2020
Moderna announced that its mRNA-1273 vaccine candidate against novel coronavirus (SARS-CoV-2) has demonstrated a significant effect in an early human trial.
Oxford Immunotec releases the T-SPOT Discovery SARS-CoV-2 kit for COVID-19 research expresspharma
May 21, 2020
This research kit could make a significant contribution towards development of a new tool to manage the COVID-19 pandemic, which in turn could help to bring nations out of their current lockdowns in a faster, safer and more controlled manner.
Potential Anti-SARS-CoV-2 Antibody Able to Inhibit In Vitro Virus Infection in Preclinical Studies americanpharmaceuticalreview
May 19, 2020
Sorrento Therapeutics announced anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration.
Vyriad to Develop Antibody Test to Determine COVID-19 Protective Immunity americanpharmaceuticalreview
May 18, 2020
Vyriad has completed the development of a serology test to measure protective immunity against SARS-CoV-2, the novel coronavirus that causes COVID-19.
Study reveals novel coronavirus may infect human intestines expresspharma
May 14, 2020
Researchers were able to isolate SARS-CoV-2 from the stool specimen of a female patient diagnosed with COVID-19, which suggests that intestinal infection may have occurred.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page